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CASE PRESENTATION
A 16-year-old boy arrived for evaluation 3 weeks
after having a cervical hyperextension injury that
occurred while wrestling. His chief complication was
increasing pain in the right upper back and neck and
paresthesias along the ulnar aspect of his right arm
and hand.
The medical history was significant for smoking
one pack of cigarettes per day and a history of fre-
quent epistaxis. At 14 years he required surgical
repair of a right superficial femoral artery injury
resulting from blunt trauma that occurred while
playing football. The patient denied any personal or
family history of easy bruisability, poor wound heal-
ing, or joint dislocation.
Physical examination revealed a blood pressure
of 134/78 mm Hg in the left arm and 114/74 mm
Hg in the right arm. His pupils were asymmetric
with a right ptosis and miosis consistent with
Horner’s syndrome. The patient’s neck was tender
to palpation along the right lateral aspect, and a pul-
satile mass and bruit were present in the right su-
praclavicular area. Carotid pulses were equal and
symmetric. The right external jugular vein was dis-
tended. The cardiac rhythm was regular with a grade
II/VI systolic flow murmur. Examination of the skin
revealed numerous small scars but no visible veins or
laxity. The joints displayed normal mobility.
Neurologic examination revealed no reflex deficit
and decreased sensation along the ulnar aspect of the
right forearm and hand.
Laboratory values were all within normal limits
including a normal coagulation profile. The electro-
cardiogram was normal. On the chest x-ray film a 3
cm rounded soft tissue density was noted at the apex
of the right hemithorax. Magnetic resonance imag-
ing revealed aneurysmal dilatation of the proximal
right subclavian artery measuring 4.5 · 3.6 · 3.4 cm
in cephalocaudal, anteroposterior, and transverse
diameters (Fig. 1). Angiography confirmed the pres-
ence of a large pseudoaneurysm arising from the ori-
gin of the right subclavian artery (Fig. 2).
The patient was admitted and given atenolol and
intravenous fentanyl. His pain worsened overnight,
and he was taken to the operating department the
next day. Initially a right supraclavicular incision was
made to expose the subclavian, common carotid,
and distal innominate arteries. The phrenic, vagus,
and recurrent laryngeal nerves were preserved. The
pseudoaneurysm was 5 cm in greatest diameter and
was compressing the inferior cords of the brachial
plexus, the common carotid artery, and the internal
jugular vein. Control of the innominate, subclavian,
and common carotid arteries was obtained. Because
of severe attenuation of the innominate artery, the
supraclavicular incision was extended to a median
sternotomy for exposure of the proximal innominate
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artery at the level of the aortic arch. During contin-
uous neurologic monitoring an aortocarotid bypass
was performed with a 7 mm knitted Dacron graft
(Meadox Hemashield). A bypass from this graft to
the distal subclavian artery was also performed with
a 7 mm Dacron graft. All anastomoses were per-
formed with running 6-0 polypropylene suture
material and Teflon pledgets. After surgery the
patient did well and was discharged on the fifth post-
operative day.
Pathologic evaluation of the subclavian artery
and associated pseudoaneurysm showed medial
degeneration, focal transmural disruption, and an
increase in acid mucopolysaccharides (confirmed by
alcian blue stain). Trichrome stain demonstrated
focal necrosis of muscle fibers and increased collagen
in the media.
Because of the abnormal pathologic findings and
history of two arterial disruptions, further workup
was recommended. Skin biopsy and fibroblast cul-
ture revealed decreased secretion of type III procol-
lagen and a heterogeneous population of type III
collagen consistent with the diagnosis of type IV
Ehlers-Danlos Syndrome (EDS). Molecular studies
on the fibroblasts with single-stranded conforma-
tional polymorphism screening and direct sequenc-
ing of cDNA revealed a point mutation in the
COL3A1 gene that encodes type III procollagen.
The point mutation resulted in the substitution of
cysteine for glycine at amino acid 52 within the
triple helical region of the a -1 chain of type III col-
lagen. Genetic studies of this patient’s mother and
siblings were negative for this mutation.
DISCUSSION
Ten types of EDS have been described, most of
which are associated with skin hyperextensibility and
joint hypermobility but no significant vascular man-
ifestations.1,2 It is important to differentiate type IV
EDS because of the unique complications of arteri-
al, colonic, and uterine rupture.
First described by Sack3 in 1936 and later rec-
ognized as a distinct clinical entity by Barabas4 in
1966, type IV EDS (vascular or ecchymotic type) is
a rare form of EDS with a prevalence of less than 1
in 100,000. Patients often die before their fourth
decade of life, and survival beyond 50 years is rare.5
It is inherited in an autosomal dominant fashion
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Fig. 2. Angiography confirmed presence of large pseudoa-
neurysm arising from origin of right subclavian artery.
Fig. 3. Point mutations in COL3A1 gene that give rise to
EDS type IV phenotype. Mutations are gathered from
published sources and unpublished data. (Reproduced
with permission from Byers PH. Ehlers-Danlos syndrome.
In: Rimoin DL, Connor JM, Pyeritz RE, editors. Emory
and Rimoin’s principles and practice of medical genetics.
3rd ed. New York: Churchill Livingstone; 1996. p. 1067-
81.) Triple helix of pro a -1 chain of type III procollagen
is indicated by line. Positions of mutations are indicated,
and substitutions for glycine residues are indicated by
G373R, for example, which indicates that glycine at posi-
tion 373 of triple helix has been replaced by arginine.
Arrow indicates position of unique point mutation
(G52C) in case presented.
Fig. 1. Magnetic resonance imaging revealed aneurysmal
dilatation of proximal right subclavian artery measuring
4.5 · 3.6 · 3.4 cm in cephalocaudal, anteroposterior, and
transverse diameters.
with many cases of spontaneous mutations. The
diagnosis can be difficult, and the condition is fre-
quently misdiagnosed as a coagulopathy. The phe-
notype is characterized by thin translucent skin with
a prominent venous pattern and marked bruising.
Joint hypermobility is limited to the small joints of
the hands and feet. The major clinical manifesta-
tions of type IV EDS are arterial rupture, sponta-
neous rupture of the colon (usually the sigmoid),
and rupture of the gravid uterus (usually during the
third trimester). Arterial rupture is the cause of
death in 90% of cases, primarily from catastrophic
hemorrhage from smaller vessels within the abdom-
inal cavity.6,7
The patient described in this report underwent
surgical repair of a large subclavian artery pseudoa-
neurysm. Typical findings of arterial friability and
attenuation were noted, and meticulous surgical
technique resulted in a successful vascular recon-
struction. Confirmation of the diagnosis can be
made by quantitative and qualitative measurement
of type III collagen in cultured dermal fibroblasts or
by direct genetic analysis, both of which were done
in this patient.8,9
Type IV EDS is a dominantly inherited connec-
tive tissue disorder that results from abnormalities in
the structure, synthesis, or secretion of type III col-
lagen. Type III collagen is normally a triple helix
composed of three procollagen molecules, each con-
taining 1029 amino acids. Critical to the stability of
the triple helix is a glycine amino acid in every third
position. Larger amino acids disrupt the helical sta-
bility and interfere with normal extracellular trans-
port of collagen. Any mutation that changes the
ability of collagens to form triple helixes or fibrils
affects stabilization of the collagen molecule and
thus interferes with normal tissue strength.
The diagnosis of type IV EDS can be made by skin
biopsy and fibroblast culture with gel electrophoresis
of collagens. This patient was found to have decreased
secretion of type III procollagen and a heterogeneous
population of type III collagen. Molecular studies on
the fibroblasts with single-stranded conformational
polymorphism screening and direct sequencing of
complimentary DNA revealed a previously unde-
scribed point mutation of the COL3A1 gene that
encodes the chains of type III procollagen. This point
mutation and other previously reported point muta-
tions in the COL3A1 gene are illustrated in Fig. 3.
Further familial studies proved that this patient had a
new mutation in the COL3A1 gene, seen in approxi-
mately 50% of cases. Therefore his siblings are not at
risk for similar problems.
Management of type IV EDS consists of mini-
mizing the risk of trauma by avoiding contact sports,
heavy exercise, and Valsalva maneuvers. No specific
medical treatment is available for the disease, and
surgical intervention for the previously described
vascular and gastrointestinal complications is often
challenging. Magnetic resonance angiography may
be helpful in defining vascular disease and avoiding
potential complications of invasive arteriography.
Because of arterial friability, delayed healing, and a
tendency for problems to recur after surgery, elective
surgery should be avoided when possible, and emer-
gency surgery ideally should be performed after spe-
cial preparation by the anesthesiologist10 and the
surgical team.6
The molecular studies presented in this report were
performed in the laboratory of Dr. Peter Byers at the
University of Washington. The authors thank Dr. Byers,
Melanie Pepin, and Dr. Ulrike Schwarze for their contri-
butions.
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